Hi cgt
I think that the next study using only infected people will be the big deal, if they can show a result in that even with a limited amount of people in it, it could be very telling. Shouldn't be hard to find the people needed and would only take a few months to do to get the results. But IF it shows a good result it could put us ahead of the rest. IF its all bad then it might be the end point without spending a great deal more money. So IMO AHZ is going about it the right way to either save us some money or put us in front of the rest with there and our goals/ endpoints
updated ballieu report - target range 25-55c, page-51
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |